CAPRICOR THERAPEUTICS, INC.CAPR

Market cap

$1.2B

P/E ratio

	Dec 31, 2011	Dec 31, 2012	Dec 31, 2013	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Revenue	-	-	-	-	-	-	-	2	1	310,250	244,898	3	25	22
TOTAL REVENUE	2	2	-	5	6	4	3	2	1	310,250	244,898	3	25	22
Research and development	30	31	11	8	14	16	11	12	5	8	14	22	36	50
General and administrative	16	18	7	3	4	5	5	5	4	6	8	10	13	15
TOTAL OPERATING EXPENSES	46	49	18	11	18	21	16	17	9	14	21	32	49	65
LOSS FROM OPERATIONS	-4,899,180	-2,440,140	-6,902,900	-6,017,985	-12,611,826	-16,976,518	-12,862,397	-15,327,086	-7,733,888	-13,689,971	-20,938,442	-29,697,383	-24,077,859	-42,564,842
Other income	-	-	-	-	-	-	-	-	-	-	548,207	190,582	67,657	7,471
Investment income	-	-	150,891	1,898	3,113	14,407	38,494	135,991	94,791	32,943	57,460	521,535	2	2
Loss on disposal of fixed assets	-1,501	-	-	-	-	-	-	-	-2,720	-	-7,905	-34,266	-6,041	-112,805
TOTAL OTHER INCOME (EXPENSE)	14,394	547,103	-1,826,243	-198,607	-245,513	-1,830,258	15	135,991	92,071	32,943	915,922	677,851	2	2
NET LOSS	-4,884,786	-46,708,017	-8,891,924	-6,216,592	-12,857,339	-18,806,776	2	-15,191,095	-7,641,817	-13,657,028	-20,022,520	-29,019,532	-22,287,542	-40,467,186
Net unrealized gain on marketable securities	-	-	20,815	980	9,385	-5,861	8,096	773	-13,150	757	-	105,244	130,569	791,142
COMPREHENSIVE LOSS	-	-	-	-6,215,612	-12,847,954	-18,812,637	2	-15,190,322	-7,654,967	-13,656,271	-20	-29	-22	-40
Earnings Per Share, Basic	-	-	-	-	-	-	0.1	-	-	-	-0.87	-1.18	-0.83	-1.15
Earnings Per Share, Diluted	-	-	-	-	-	-	0.09	-0.52	-	-	-0.87	-1.18	-0.83	-1.15